Join @NorthwestBio on Sunday, June 3, at 4:15 (CT) at #ASCO2018 as Dr. Marnix L. Bosch, Chief Technical Officer of NW Bio, will discuss the interim data that was published on May 29 from the Company’s Phase 3 trial of DCVax®-L for newly diagnosed #Glioblastoma brain #cancer.